A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer.

Background The glycolytic nature of cancer cells presents a potential treatment target that may be addressed by a ketogenic diet (KD). Objective We hypothesized that a KD would improve body composition and lower serum insulin and insulin-like growth factor-I (IGF-I) in women with ovarian or endometrial cancer. Methods In this randomized controlled trial, women with ovarian or endometrial cancer [age: ≥19 y; body mass index (kg/m2): ≥18.5] were randomly assigned to a KD (70:25:5 energy from fat, protein, and carbohydrate) or the American Cancer Society diet (ACS; high-fiber, low-fat). Body composition (DXA) and fasting serum insulin, IGF-I, and β-hydroxybutyrate were obtained at baseline and at 12 wk; urinary ketones were also measured throughout the intervention. We assessed differences between the diets with ANCOVA and independent t tests. We used correlation analyses to estimate associations between changes in serum analytes and body composition. Results After 12 wk, the KD (compared with ACS) group had lower adjusted total (35.3 compared with 38.0 kg, P < 0.05) and android (3.0 compared with 3.3 kg, P < 0.05) fat mass. Percentage of change in visceral fat was greater in the KD group (compared with the ACS group; -21.2% compared with -4.6%, P < 0.05). Adjusted total lean mass did not differ between the groups. The KD (compared with ACS) group had lower adjusted fasting serum insulin (7.6 compared with 11.2 µU/mL, P < 0.01). There was a significant inverse association between the changes in serum β-hydroxybutyrate and IGF-I concentrations (r = -0.57; P < 0.0001). Conclusions In women with ovarian or endometrial cancer, a KD results in selective loss of fat mass and retention of lean mass. Visceral fat mass and fasting serum insulin also are reduced by the KD, perhaps owing to enhanced insulin sensitivity. Elevated serum β-hydroxybutyrate may reflect a metabolic environment inhospitable to cancer proliferation. This trial was registered at www.clinicaltrials.gov as NCT03171506.

[1]  S. Nam,et al.  Visceral Adipose Tissue Volume and the Occurrence of Colorectal Adenoma in Follow-up Colonoscopy for Screening and Surveillance , 2017, Nutrition and cancer.

[2]  A. Gasbarrini,et al.  Efficacy and safety of very-low-calorie ketogenic diet: a double blind randomized crossover study. , 2017, European review for medical and pharmacological sciences.

[3]  F. Casanueva,et al.  Body Composition Changes After Very-Low-Calorie Ketogenic Diet in Obesity Evaluated by 3 Standardized Methods , 2017, The Journal of clinical endocrinology and metabolism.

[4]  F. Casanueva,et al.  Obesity treatment by very low-calorie-ketogenic diet at two years: reduction in visceral fat and on the burden of disease , 2016, Endocrine.

[5]  A. Liman,et al.  Modified Atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System , 2016, Nutrition & Metabolism.

[6]  R. Sweeney,et al.  Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients , 2016, BMC Research Notes.

[7]  Guoxing Zhang,et al.  Incidence and risk factor analysis for sarcopenia in patients with cancer. , 2016, Oncology letters.

[8]  H. Walach,et al.  The development of tumours under a ketogenic diet in association with the novel tumour marker TKTL1: A case series in general practice , 2015, Oncology letters.

[9]  R. Glynn,et al.  Prospective study of body size throughout the life‐course and the incidence of endometrial cancer among premenopausal and postmenopausal women , 2015, International journal of cancer.

[10]  C. Ebbeling,et al.  Relationship of Insulin Dynamics to Body Composition and Resting Energy Expenditure following Weight Loss , 2015, Obesity.

[11]  B. Gower,et al.  Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS. , 2014, Metabolism: clinical and experimental.

[12]  J. Buatti,et al.  Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism , 2014, Redox biology.

[13]  S. Cummings,et al.  Association of total adiposity and computed tomographic measures of regional adiposity with incident cancer risk: a prospective population-based study of older adults. , 2014, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[14]  James J. Evans,et al.  Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme , 2014, Journal of Neuro-Oncology.

[15]  D. Leroith,et al.  Insulin and IGFs in Obesity-Related Breast Cancer , 2013, Journal of Mammary Gland Biology and Neoplasia.

[16]  B. Gower,et al.  Favourable metabolic effects of a eucaloric lower‐carbohydrate diet in women with PCOS , 2013, Clinical endocrinology.

[17]  W. Qi,et al.  Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth , 2013, PloS one.

[18]  N. Simone,et al.  Selectively starving cancer cells through dietary manipulation: methods and clinical implications. , 2013, Future oncology.

[19]  L. R. Young,et al.  Low-fat diet with omega-3 fatty acids increases plasma insulin-like growth factor concentration in healthy postmenopausal women. , 2013, Nutrition research.

[20]  A. Paoli,et al.  Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets , 2013, European Journal of Clinical Nutrition.

[21]  Brian J. Smith,et al.  Ketogenic Diets Enhance Oxidative Stress and Radio-Chemo-Therapy Responses in Lung Cancer Xenografts , 2013, Clinical Cancer Research.

[22]  T. Seyfried,et al.  The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer , 2013, PloS one.

[23]  B. Gower,et al.  Effects of diet macronutrient composition on body composition and fat distribution during weight maintenance and weight loss , 2013, Obesity.

[24]  W. Demark-Wahnefried,et al.  Obesity, Energy Balance, and Cancer: New Opportunities for Prevention , 2012, Cancer Prevention Research.

[25]  Derek LeRoith,et al.  Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. , 2012, Endocrine-related cancer.

[26]  A. Negassa,et al.  Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. , 2012, Nutrition.

[27]  U. Smith,et al.  Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro , 2012, Diabetologia.

[28]  C. Rock,et al.  Nutrition and physical activity guidelines for cancer survivors , 2012, CA: a cancer journal for clinicians.

[29]  P. Stafford,et al.  The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma , 2012, PloS one.

[30]  Andy H. Lee,et al.  Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies , 2012, The Lancet. Oncology.

[31]  Andy H. Lee,et al.  Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies , 2012, PLoS medicine.

[32]  Gary Taubes,et al.  Cancer research. Unraveling the obesity-cancer connection. , 2012, Science.

[33]  K. Siddle,et al.  Molecular Basis of Signaling Specificity of Insulin and IGF Receptors: Neglected Corners and Recent Advances , 2011, Front. Endocrin..

[34]  U. Kämmerer,et al.  Is there a role for carbohydrate restriction in the treatment and prevention of cancer? , 2011, Nutrition & metabolism.

[35]  Mélanie Schmidt,et al.  Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial , 2011, Nutrition & metabolism.

[36]  B. Nelson,et al.  A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation. , 2011, Cancer research.

[37]  J. Reynolds,et al.  Visceral adiposity, insulin resistance and cancer risk , 2011, Diabetology & metabolic syndrome.

[38]  R. Schugar,et al.  Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[39]  P. Goodwin,et al.  Understanding the benefit of metformin use in cancer treatment , 2011, BMC medicine.

[40]  A. Hoeflich,et al.  Lack of dietary carbohydrates induces hepatic growth hormone (GH) resistance in rats. , 2011, Endocrinology.

[41]  P. Stafford,et al.  The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma , 2010, Nutrition & metabolism.

[42]  Andrew W Roddam,et al.  Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies , 2010, The Lancet. Oncology.

[43]  T. Seyfried,et al.  Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report , 2010, Nutrition & metabolism.

[44]  F. Clavel-Chapelon,et al.  Serum levels of IGF‐I, IGFBP‐3 and colorectal cancer risk: results from the EPIC cohort, plus a meta‐analysis of prospective studies , 2010, International journal of cancer.

[45]  R. Feinman,et al.  Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2 , 2009, Cancer Cell International.

[46]  W. Kraemer,et al.  Carbohydrate Restriction has a More Favorable Impact on the Metabolic Syndrome than a Low Fat Diet , 2009, Lipids.

[47]  F. Frasca,et al.  The role of insulin receptors and IGF-I receptors in cancer and other diseases , 2008, Archives of physiology and biochemistry.

[48]  A. Manninen.  Very-low-carbohydrate diets and preservation of muscle mass , 2006, Nutrition & metabolism.

[49]  C. Homko,et al.  Effect of a Low-Carbohydrate Diet on Appetite, Blood Glucose Levels, and Insulin Resistance in Obese Patients with Type 2 Diabetes , 2005, Annals of Internal Medicine.

[50]  Matthias Egger,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.

[51]  R. Kaaks.  Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. , 2004, Novartis Foundation symposium.

[52]  T. Seyfried,et al.  Role of glucose and ketone bodies in the metabolic control of experimental brain cancer , 2003, British Journal of Cancer.

[53]  Domenico Coppola,et al.  Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. , 2003, Human pathology.

[54]  W. Kraemer,et al.  Body composition and hormonal responses to a carbohydrate-restricted diet. , 2002, Metabolism: clinical and experimental.

[55]  S. Kihara,et al.  Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial. , 2001, Diabetes research and clinical practice.

[56]  J. Thoen,et al.  Reduction in serum leptin and IGF-1 but preserved T-lymphocyte numbers and activation after a ketogenic diet in rheumatoid arthritis patients. , 2000, Clinical and experimental rheumatology.

[57]  L. Lutwak,et al.  Effect of body composition and other parameters in obese young men of carbohydrate level of reduction diet. , 1971, The American journal of clinical nutrition.